We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Clinical Omics and Mass Spectrometry
Listicle

Clinical Omics and Mass Spectrometry

Clinical Omics and Mass Spectrometry
Listicle

Clinical Omics and Mass Spectrometry

Results of large-scale omics studies have led to significant advances in the biomedical understanding of a variety of biological phenomena, including the development and progression of cancer and other diseases. 

Due to its broad-based applicability to detect compounds with a wide range of masses, along with its high sensitivity, mass spectrometry (MS) has been used extensively in a range of omics analyses and applications. In this listicle, we explore the use of MS-based data in a variety of clinical omics settings.

Download this listicle to find out more about:

  • Clinical omics and infectious diseases
  • Detection and monitoring of food allergens
  • Limitations of MS for clinical omics and comparison to other methods
Meet the Author
Mindy Levine, PhD
Mindy Levine, PhD
Advertisement